| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/17/2011 | WO2011017106A9 Skp2 as a biomarker for rapamycin resistance |
| 03/17/2011 | WO2011010304A3 Method for preparing molecularly imprinted polymers and uses thereof |
| 03/17/2011 | WO2011008785A3 A method of analyzing cellulose decay in cellulosic material hydrolysis |
| 03/17/2011 | WO2011003598A3 Detection of antigens |
| 03/17/2011 | WO2010142651A3 Method for determining the risk of developing brain metastasis, and a kit to carry out said method |
| 03/17/2011 | WO2010132208A3 Diagnostic methods for liver disorders |
| 03/17/2011 | WO2010129713A3 Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject |
| 03/17/2011 | WO2010126614A3 Methods and compositions for evaluating genetic markers |
| 03/17/2011 | WO2010121834A3 Irak kinase family as novel target and biomarker for alzheimer |
| 03/17/2011 | WO2010120069A3 Antigenic protein of black-lip pearl oyster egg extract, and method for assessing productive effort of black-lip pearl oyster using antibody specific to the protein |
| 03/17/2011 | WO2010111215A4 Compositions and methods for treatment of hemorrhage |
| 03/17/2011 | US20110067126 Gab1 involvement in glucose homeostasis regulation by hepatocytes |
| 03/17/2011 | US20110067124 Detection and treatment of drug associated angioedema |
| 03/17/2011 | US20110067123 Mao-b elevation as an early parkinson's disease biomarker |
| 03/17/2011 | US20110067121 Transgenic mice having a human major histocompatibility complex (MHC) phenotype, experimental uses and applications |
| 03/17/2011 | US20110067120 Iduronidase knock-out mouse |
| 03/17/2011 | US20110066581 Class I and Class II MHC Profiling for Social and Sexual Matching of Human Partners |
| 03/17/2011 | US20110066385 Quantification of differences between measured values and statistical validation based on the differences |
| 03/17/2011 | US20110066060 Apparatus and method for diagnostic gas analysis |
| 03/17/2011 | US20110066019 Biosensor Membranes Composed Of Polymers Containing Heterocyclic Nitrogens |
| 03/17/2011 | US20110065898 Immunosuppressant Target Proteins |
| 03/17/2011 | US20110065773 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110065758 Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions |
| 03/17/2011 | US20110065715 Nogo Receptor Binding Small Molecules to Promote Axonal Growth |
| 03/17/2011 | US20110065661 Pharmacoperones for correcting disease states involving protein misfolding |
| 03/17/2011 | US20110065650 Methods of Inhibiting Tumor Cell Proliferation |
| 03/17/2011 | US20110065649 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 03/17/2011 | US20110065609 Methods and Kits for the Diagnosis of Rheumatoid Arthritis |
| 03/17/2011 | US20110065605 Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith |
| 03/17/2011 | US20110065590 Method and Apparatus for Performing Microassays |
| 03/17/2011 | US20110065587 Epitope testing using soluble hla |
| 03/17/2011 | US20110065213 Method for immunoassay using latex particles |
| 03/17/2011 | US20110065212 Graft polymer-containing substrate, method for producing the same, target substance-detecting element, and target substance detection kit |
| 03/17/2011 | US20110065211 Device and methods for detecting analytes in saliva |
| 03/17/2011 | US20110065210 Use of B-Type Natriuretic Peptide as a Prognostic Indicator in Acute Coronary Syndromes |
| 03/17/2011 | US20110065209 Integrated Sample Preparation and Analyte Detection |
| 03/17/2011 | US20110065208 Determination and estimation of absorption and distribution of substances in brain tissue |
| 03/17/2011 | US20110065207 Combinatorial multidomain mesoporous chips and a method for fractionation, stabilization, and storage of biomolecules |
| 03/17/2011 | US20110065206 Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents |
| 03/17/2011 | US20110065205 Method for determining prognosis of acute central nervous system disorder |
| 03/17/2011 | US20110065204 Assessing risk of cardiac intervention based on gdf-15 |
| 03/17/2011 | US20110065202 Method for Examination of Alzheimer's Disease |
| 03/17/2011 | US20110065201 Nanostructure material with metallic oxide and method for detecting phosphorus-containing compounds |
| 03/17/2011 | US20110065200 Use of alpha-methylglucoside (amg) as an indicator for glucose absorption and excretion |
| 03/17/2011 | US20110065199 Atherosclerosis marker and use thereof |
| 03/17/2011 | US20110065198 Novel targets and compounds for therapeutic intervention of hiv infection |
| 03/17/2011 | US20110065197 Diagnostic kit for alzheimer's disease, diagnostic marker, and detection method for indicator of pathological state thereof |
| 03/17/2011 | US20110065196 Trityl Derivatives for Enhancing Mass Spectrometry |
| 03/17/2011 | US20110065195 Terpyridine-substituted compounds and related selective detection methods |
| 03/17/2011 | US20110065183 Methods and Apparatus for Isolating Platelets From Blood |
| 03/17/2011 | US20110065172 Direct mixing and injection for high throughput fluidic systems |
| 03/17/2011 | US20110065148 Peptides and uses thereof |
| 03/17/2011 | US20110065147 Methods and reagents for modulating cholesterol levels |
| 03/17/2011 | US20110065139 diagnostic device for identifying rupture of membrane during pregnancy |
| 03/17/2011 | US20110065137 Methods and Devices for Detecting Obstructive Uropathy and Associated Disorders |
| 03/17/2011 | US20110065136 Methods and Devices for Detecting Glomerulonephritis and Associated Disorders |
| 03/17/2011 | US20110065135 Liposome composition, its production process, and method for analyzing analyte using the same |
| 03/17/2011 | US20110065134 Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies |
| 03/17/2011 | US20110065133 O-ring Systems and Methods for Quantification of Multiplex Biomarkers in Multiple Samples |
| 03/17/2011 | US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases |
| 03/17/2011 | US20110065131 Assays for mutagenesis detection |
| 03/17/2011 | US20110065130 Diagnosing and Grading Gliomas Using a Proteomics |
| 03/17/2011 | US20110065129 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/17/2011 | US20110065128 Methods for Assessing CDK5 Activation and Function |
| 03/17/2011 | US20110065127 Detection of Degradative Enzymes and Biomolecules in Bodily Fluids |
| 03/17/2011 | US20110065126 Substance-immobilizing substrate, substance-immobilized subtrate, and analysis method |
| 03/17/2011 | US20110065125 Controlled platelet activation to monitor therapy of adp antagonists |
| 03/17/2011 | US20110065124 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 03/17/2011 | US20110065123 Methods for diagnosis of Clostridium difficile and methods and vectors for recombinant toxin expression |
| 03/17/2011 | US20110065122 Method for accessing microbial diversity |
| 03/17/2011 | US20110065121 Method for the detection of apoptosis |
| 03/17/2011 | US20110065120 Method and a Reagent kit to Improve the Accuracy of Sample Classification |
| 03/17/2011 | US20110065118 Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells |
| 03/17/2011 | US20110065114 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals |
| 03/17/2011 | US20110065109 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110065104 Real-time assays of neuro-humoral factors to assess cardiovascular stress |
| 03/17/2011 | US20110065099 Method of pretreating specimen and immunoassay using the same |
| 03/17/2011 | US20110065098 Methods and reagent kits for improving accuracy of sample classification |
| 03/17/2011 | US20110065092 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 03/17/2011 | US20110065091 Coronavirus, Nucleic Acid, Protein, and Methods for the Generation of Vaccine, Medicaments and Diagnostics |
| 03/17/2011 | US20110065090 Asymmetrically branched polymer conjugates and microarray assays |
| 03/17/2011 | US20110065089 Novel strain of sars-associated coronavirus and applications thereof |
| 03/17/2011 | US20110065088 Method and devices for rapid diagnosis of foot-and-mouth disease |
| 03/17/2011 | US20110064847 Method of denaturing protein with enzymes |
| 03/17/2011 | US20110064761 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 03/17/2011 | US20110064759 Method for the Identification of Extracellular Domains of Epstein Barr Virus (EBV) Tumor-Associated Latent Membrane Proteins and for the Selection of Antibody Reagents Reactive Therewith |
| 03/17/2011 | US20110064757 Nucleic acid molecules and polypeptides for immune modulation |
| 03/17/2011 | US20110064756 Novel sequences of brachyspira, immunogenic compounds, methods for preparation and use thereof |
| 03/17/2011 | US20110064747 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10) |
| 03/17/2011 | US20110064743 Human anti-cancer antibodies |
| 03/17/2011 | US20110064741 Stable amyloid beta monomers and oligomers |
| 03/17/2011 | US20110064739 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064732 Methods and compositions for diagnostic use in cancer patients |
| 03/17/2011 | US20110064725 High affinity, anti-human ige antibodies |
| 03/17/2011 | US20110064724 Methods for Identifying Compounds for the Treatment of Type 1 Diabetes |
| 03/17/2011 | US20110064722 Modulators of alpha-synuclein toxicity |
| 03/17/2011 | US20110064715 Methods for determining oligosaccharide binding |
| 03/17/2011 | US20110064701 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/17/2011 | US20110064666 Compound |